N-Deacetylcolchicine (CAS 3476-50-4)

LRF Inhibitors are a class of chemical compounds that specifically target the Leukemia/Lymphoma Related Factor (LRF), also known as ZBTB7A, a member of the Zinc finger and BTB domain-containing (ZBTB) family of transcription factors. ZBTB proteins are characterized by the presence of a BTB/POZ domain, which mediates protein-protein interactions, and a zinc finger domain, which facilitates DNA binding. LRF, as a ZBTB protein, plays a crucial role in regulating gene expression by binding to specific DNA sequences and recruiting co-repressor complexes to modulate chromatin structure and transcriptional activity. This regulatory function is vital for various cellular processes, including cell differentiation, proliferation, and apoptosis. Inhibitors of LRF provide researchers with a unique tool to dissect the molecular mechanisms through which LRF and other ZBTB proteins exert their influence on cellular functions. The inhibition of LRF activity by specific inhibitors allows scientists to explore the broader functional roles of ZBTB proteins in gene regulation. By blocking the interaction of LRF with its target DNA sequences or its associated co-repressor complexes, LRF Inhibitors can disrupt the repressive transcriptional programs that LRF orchestrates. This disruption leads to changes in gene expression patterns, providing valuable insights into the epigenetic and transcriptional networks controlled by LRF and related ZBTB proteins. Furthermore, the study of LRF Inhibitors in the context of ZBTB proteins sheds light on the broader family′s involvement in maintaining cellular homeostasis and responding to environmental cues. As ZBTB proteins are known to regulate a wide array of genes involved in critical biological processes, LRF Inhibitors serve as a crucial tool for understanding the intricate regulatory pathways that these proteins modulate, thereby advancing our knowledge of cellular biology and gene regulation.